The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions

A widely repeated interaction claim that turns out to be unsupported

NK
n.kirchnerTL217 Oct 2025#1

On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion.

I was wrong about widely repeated interaction claim in a thread last spring and I would like to correct it publicly rather than quietly.

The error was in the units, which changed the conclusion by an order of magnitude. Setting out the corrected version, and the way I now check for that class of mistake.

6 likes 9mo
RG
r.girardTL226 Oct 2025#2

The opening post and I disagree about the size of the effect, not about the direction.

Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the conservative reading is the obvious one.

10 likes 9mo
BN
b.nwosuTL22 Nov 2025#3
n.kirchner, post #1: On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. I was wrong about widely repeated interaction claim in a thread last spring and I would like to correct it publicly rather than quietly. The error was in the units, which changed the conclusion by an… Go to post

A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not have.

If that is already documented somewhere, ignore me and link it.

23 likes in reply to #1 9mo
MS
m.stephanopoulosTL3Regular8 Nov 2025#4
n.kirchner, post #1: On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. I was wrong about widely repeated interaction claim in a thread last spring and I would like to correct it publicly rather than quietly. The error was in the units, which changed the conclusion by an… Go to post

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

The strength of my opinion here exceeds the strength of my evidence.

0 likes in reply to #1 9mo
DT
d.tammTL214 Nov 2025#5

Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as one.

That is all I can say without guessing.

6 likes 8mo
BF
b.fonsecaTL219 Nov 2025#6

Worth separating two things that post #4 runs together.

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

15 likes 8mo
CS
c.silvaTL224 Nov 2025 · edited#7
b.fonseca, post #6: Worth separating two things that post #4 runs together. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a prescribing question and not a forum question.

The disagreement above is smaller than it looks once the terms are fixed.

30 likes in reply to #6 8mo
AZ
a.zamoraTL228 Nov 2025#8

Two things can be true about widely repeated interaction claim at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people defending the first against attacks on the second.

0 likes 8mo
DN
d.ndiayeTL23 Dec 2025#9

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

That much is documented. The rest is how I have interpreted it.

10 likes 8mo
W
WickramasingheTL2Member8 Dec 2025#10
b.fonseca, post #6: Worth separating two things that post #4 runs together. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist.

The step people skip is the one I have spelled out.

22 likes in reply to #6 8mo
BE
bench_entryTL3Regular12 Dec 2025#11

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

20 likes 8mo
PD
p.dialloTL216 Dec 2025#12

Post #11 is right about the mechanism and I think understates the practical bit.

A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is usually worse rather than better.

That is the practical version. The rigorous version is longer and says the same thing.

8 likes 7mo
BS
buffer_sheetTL321 Dec 2025#13
BW
b.wikstromTL225 Dec 2025#14
d.ndiaye, post #9: Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction. That much is documented. The rest is how I have interpreted it. Go to post

The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather than filling the gap.

Two sources, same conclusion, and I could not rule out that one copied the other.

0 likes in reply to #9 7mo
SG
s.grahameTL2Member29 Dec 2025#15

I had written a reply contradicting post #11 and deleted it. Here is what survived.

Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.

This is the sort of thing the wiki should carry and currently does not.

14 likes 7mo
ER
e.roosTL22 Jan 2026 · edited#16

Post #15 is right about the mechanism and I think understates the practical bit.

Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful than reasoning from mechanism alone.

This is the sort of thing that ought to be settled and apparently is not.

5 likes 7mo
ED
e.dalgleishTL3Regular6 Jan 2026#17

Understood. Thank you for being specific about the limits of it.

0 likes 7mo
RI
r.ilungaTL210 Jan 2026#18
buffer_sheet, post #13: On post #11 — agreed on the reasoning, with one qualification. Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in most published cases. It cost nothing to check and would have cost something not to. Go to post

Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance would suggest.

28 likes in reply to #13 7mo
D
DOdendaalTL3Regular13 Jan 2026#19

Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.

The claim is narrower than it sounds, and deliberately so.

0 likes 6mo
MB
ma.balogunTL217 Jan 2026#20
VB
va.baptistaTL221 Jan 2026#21

Building on post #19 rather than restating it.

Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.

The variance between people here is larger than the effect being discussed.

13 likes 6mo
TV
t.vasquezTL4 Moderator25 Jan 2026#22

Post #18 put the caveat in the right place and I want to underline it.

Having read the whole widely repeated interaction claim thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one instead.

26 likes 6mo
JA
j.asanteTL228 Jan 2026#23
e.roos, post #16: Post #15 is right about the mechanism and I think understates the practical bit. Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful than reasoning from mechanism alone. This is the sort of thing that ought to be settled… Go to post

Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an argument for spacing them.

0 likes in reply to #16 6mo
CR
compounding_ruthTL4Pharmacist1 Feb 2026#24

Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.

2 likes 6mo
HD
h.delgadoTL25 Feb 2026#25

Trying to state the widely repeated interaction claim position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.

18 likes 6mo
SS
system_suitabilityTL38 Feb 2026#26
JM
j.moreauTL212 Feb 2026#27
e.dalgleish, post #17: Understood. Thank you for being specific about the limits of it. Go to post

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

Not the whole picture, but the part of it I can speak to.

0 likes in reply to #17 5mo
KO
k.otieno_statsTL3Statistician15 Feb 2026 · edited#28

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

4 likes 5mo
OC
o.cousineauTL3Regular19 Feb 2026#29

Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.

25 likes 5mo
AS
a.silvaTL222 Feb 2026#30
va.baptista, post #21: Building on post #19 rather than restating it. Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual. The variance between people here is larger than the effect being discussed. Go to post

Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in most published cases.

0 likes in reply to #21 5mo